What kind of ester could allow an injection to last for 3 months?
Nebido® is the first 3-monthly injectable testosterone preparation for the treatment of testosterone deficiency.
Nebido® reliably alleviates symptoms and prevents consequences of testosterone deficiency such as decreased sexual desire, decreased muscle mass and strength, fatigue, depressive mood as well as a lacking of, incomplete development, or regression of secondary sexual characteristics, and an increased risk of osteoporosis.
Patients value the consistent, reliable efficacy and the long duration of effect. Nebido® liberates patients from the burden of approximately 20 injections of conventional testosterone therapy per year. In contrast, only four injections of Nebido® are required per year.
Nebido® will be introduced in Europe, starting in Finland and Germany, autumn 2004. Other European countries will follow in 2005. Launches in Latin American and Asian will start 2005.